Dexamethasone phosphate (as sodium); 4mg/mL, 10mg/mL; soln for IV or IM inj; contains sulfites. Potentiated by CYP3A4 inhibitors (eg, ketoconazole, macrolides), cyclosporine, estrogens. Antagonized by ...
Ranibizumab, an anti-vascular endothelial growth factor, and dexamethasone, a corticosteroid, have been shown to be effective in treating macular oedema secondary to retinal vein occlusion (RVO) ...
The Diabetic Retinopathy Clinical Research Network conducted a phase 2, multicenter, randomized, prospective clinical trial examining the effects of adding intravitreal dexamethasone to ranibizumab in ...
September 28, 2010 — The US Food and Drug Administration (FDA) has approved a dexamethasone 0.7 mg intravitreal implant (Ozurdex; Allergan, Inc) for the treatment of noninfectious ocular inflammation ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I being treated with DBL Dexamethasone Sodium Phosphate ...
A low-cost steroid may save the lives of some people who are on ventilators or supplemental oxygen because of COVID-19, preliminary data from a large clinical trial suggest. Dexamethasone, a steroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results